MoonLake Immunotherapeutics's total assets for Q1 2025 were $511.26M, an increase of 6.97% from the previous quarter. MLTX total liabilities were $98.68M for the fiscal quarter, a -99.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.